X0306 4/A 2012-03-15 2012-03-20 0 0001053369 ELITE PHARMACEUTICALS INC /NV/ ELTP 0001442002 EPIC PHARMA LLC 227-15 NORTH CONDUIT AVE LAURELTON NY 11413-3134 0 0 1 0 Series E Preferred Stock 0.0246 2012-03-15 4 A 0 125 1000 A 2012-03-15 Common Stock 5082301 1750 I see footnote This footnote does not relate to this amendment. See original filing. The reporting person, Epic Pharma, LLC ("EP"), is an equity owner of Epic Investments, LLC ("EI"), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer. EP and EI are both owned, wholly or in part, and are operated by Ram Potti, Ashok G. Nigalaye and Jeenarine Narine, each of whom is a director of the issuer. The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI. The grant of the Series E Preferred Stock was approved by the issuer's board of directors on March 13, 2009. This amendment is filed because the transaction was previously erroneously described as a Purchase. N/A Ram Potti 2012-08-09